Pharmacologic-only approaches to the management of chronic pain seldom provide complete/adequate pain relief and experts advocate for an integrative approach to the management of chronic pain.
New evidence suggests that stopping antibiotics sooner is a safe and effective way to reduce antibiotic overuse.
Boehringer Ingelheim has initiated a clinical study to investigate the interchangeability between an adalimumab biosimilar candidate and Humira.
There is good evidence for cognitive behavioral therapy and motivational approaches to dependence.
These findings highlight an urgent need to produce more evidence on the risks and benefits of off-label antidepressant use.
Much of the third world is suffering in pain without access to opioids. This imbalance has been called the opioid gap. How can we get opioids to patients who need them?
A recent study published in The Journal of Pain evaluated the effectiveness of a brief self-assessment tool called the Opioid Compliance Checklist in identifying adherence, or misuse, among patients prescribed opioids.
The drug assists the kidney excrete uric acid by impeding the function of transporter proteins involved in uric acid reabsorption in the kidney.
PAMORA strategy appears to safe with superior effectiveness.
Two new studies shed more light on whether of aspirin can help treat breast cancer patients.
Pharmacogenetic testing yields information that informs how an individual will metabolize medications.
Exposing clinicians to a multifaceted risk-reduction initiative significantly shifts prescribing practices away from high-dose chronic opioid therapy.
The FDA approval process requires 3 elements: efficacy, safety, and ability to manufacture quality product reproducibly.
Isovaline may be a new alternative to opioids for anesthesia and procedural sedation, new data published in Anesthesia & Analgesia has shown.
Treating painful conditions typically requires an approach that uses a variety of methods.
Significant reduction in drug-related problems with immediate communication of recommendations.
Clinical and community-based approaches should be used to increase aspirin use among low-use groups.
No indication any particular type of antidepressant carries a greater risk than others.
Patients who use of multiple pharmacies concurrently (pharmacy shopping) and have overlapping prescriptions for opioid medications have a greater risk of opioid overdose events.
If a compound does not pass an initial screen, a switch can be requested.
Researchers find testing blood from mouth is as accurate as finger prick at diagnosing condition
Clinical Pain Advisor Articles
- Parenteral Hydromorphone for Migraine and ED Revisits
- Tackling the Chronic Pain and Opioid Use Disorder Crises Through Public-Private Partnerships
- Pain Tolerance in Buprenorphine Maintenance Treatment
- The State of Drug Storage, Disposal Labeling Information for Opioid Analgesics
- Incidence of Musculoskeletal Disorders, Depression in Migraine
- Radiofrequency Ablation for Chronic Hip Pain: Reviewing the Evidence
- Opioid Use Disorder Treatment: Evidence-Based Guideline
- Peripheral Neuropathy Management in the Primary Care Setting: A Guide
- Betel Quid Addiction and Implications for Substance Use Disorder
- Low Back Pain: Contributing Factors, Prophylactic Strategies, and Effective Treatments
- Predicting Suicidal Ideation in Veterans With Chronic Pain
- Femoral Nerve Block Alone or in Combination With Sciatic Nerve Block for TKA: A Meta-Analysis
- Improved Care Efficiency Requires a More Manageable System
- Recommendations Developed on Gender Equity in Medicine
- Medication Adherence, Blood Pressure Reduction Assessed With Smartphone App Use